Tagged with China

AMR Still a Threat To Millions of Lives: WHO
China Pharma News: Paxlovid’s Exclusion from National Insurance; CanSino’s mRNA Booster Trial; WuXi/GSK T-cell Deal; Biocytogen/Hansoh Antibody Collab
China Pharma News: External Concern Over COVID-19 Outbreak; China Meheco Paxlovid Contract; Boston Scientific Stake in Acotec; Pfizer/LianBio Deal
Biosimilars & Biologics: China
Localization: China
Orphan Drugs & Rare Diseases: China
Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs: China
Regulatory Reforms: China
Patents & Trademarks: China
Product Liability: China
Traditional Medicines and OTC Products: China
Marketing, Manufacturing, Packaging & Labeling, Advertising: China
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here